EU picks AZ-Oxford team for first COVID-19 vaccine contract

The European Commission closed its first advance purchase agreement for a COVID-19 vaccine Friday as it nears deals for two additional vaccines.

The EC agreed to purchase 300 million doses of adenovirus vector vaccine AZD1222  from  AstraZeneca plc (LSE:AZN; NYSE:AZN) and the University of Oxford, with an option to purchase 100 million more. ...